Answers are grounded in this paper and cite their sources.
Discusses the mechanistic role of GP IIb/IIIa receptors in platelet aggregation and their importance as targets for antithrombotic therapy.
latelet aggregation is a key step in thrombus formation on the ruptured atherosclerotic plaque and after percutaneous coronary intervention (PCI). It is induced and amplified by several potent agonists, such as collagen, ADP, thromboxane A 2 , and thrombin. Each agonist binds to a specific platelet membrane receptor and signals the conformational change of glycoprotein IIb/IIIa (GP IIb/IIIa), which becomes an active receptor for fibrinogen. The binding of fibrinogen to GP IIb/IIIa mediates platelet aggregation. 1 At high shear stress, von Willebrand factor also binds to GP IIb/IIIa and contributes to platelet aggregation. 2 Thus, platelet surface GP IIb/IIIa plays a critical role in coronary arterial thrombosis and is a target for antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: